YD Bio (YDESW) Total Liabilities (2024 - 2026)
YD Bio's (YDESW) quarterly Total Liabilities came in at $5.6 million in Q2 2026, up 641.94% year-over-year from $752935.0 in Q2 2025, and down 66.42% quarter-over-quarter from $16.6 million in Q4 2025.
Analysis
YD Bio (YDESW) Total Liabilities (2024 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Total Liabilities for 3 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities rose 641.94% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 641.94% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, down 93.93% from the prior year.
- Total Liabilities was $5.6 million for Q2 2026 at YD Bio, down from $16.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $274.0 million in Q4 2024 and troughed at $752935.0 in Q2 2025.
- A 3-year average of $74.2 million and a median of $11.1 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 93.93% in 2025 and surged 641.94% in 2026, its largest moves.
- Over 3 years, Total Liabilities stood at $274.0 million in 2024, then slumped by 93.93% to $16.6 million in 2025, then slumped by 66.42% to $5.6 million in 2026.
- The last three Total Liabilities figures came in at $5.6 million (Q2 2026), $16.6 million (Q4 2025), and $752935.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn | 83.95 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn | 37.53 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn | 7.18 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 10.02 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn | 1.62 Bn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn | 4.20 Bn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn | 13.24 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn | 384.62 Mn |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - | 5.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.59 Mn |
| Dec 31, 2025 | 16.64 Mn |
| Jun 30, 2025 | 752,935.00 |
| Dec 31, 2024 | 273.98 Mn |